Standout Papers

JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib... 2021 2026 2022 2024200
  1. JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib (2021)
    Paqui G. Través, Bernard P. Murray et al. Annals of the Rheumatic Diseases

Immediate Impact

1 from Science/Nature 47 standout
Sub-graph 1 of 16

Citing Papers

Therapeutic advances in rheumatoid arthritis
2024 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
1 intermediate paper

Works of Amy Meng being referenced

JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib
2021 Standout

Author Peers

Author Last Decade Papers Cites
Amy Meng 43 87 113 60 9 225
Stina Lindblad 57 47 174 66 6 285
Regina Cseuz 57 72 142 41 7 223
Shuhei Nishimoto 53 63 72 166 6 296
Alice Lorenzi 20 31 123 140 12 264
Julie Crawford 62 163 43 39 11 254
Julie Ducreux 21 44 141 119 14 263
Suguru Honda 30 28 90 20 13 154
Kaoru Takase-Minegishi 48 58 170 55 11 271
V. Varisco 16 22 103 101 11 253
Claudia Canofari 11 21 142 61 11 242

All Works

Loading papers...

Rankless by CCL
2026